Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » US Rep. Dold Visits Feinberg to Discuss Medical Research Funding
Campus News

US Rep. Dold Visits Feinberg to Discuss Medical Research Funding

By Amber BemisSep 2, 2015
Share
Facebook Twitter Email
Roundtable
U.S. Rep. Bob Dold discusses new legislation to improve the funding of biomedical research with Teresa Woodruff, PhD, director of the Women’s Health Research Institute and chief of Fertility Preservation in the Department of Obstetrics and Gynecology.

Scientists from Northwestern University Feinberg School of Medicine met with U.S. Rep. Robert Dold (IL-10) Monday to discuss federal funding of medical research and progress surrounding legislation to improve biomedical research and healthcare innovation.

Among participants at the roundtable discussion, there was broad agreement on a common goal: the need for more federal funding of medical research to accelerate progress toward new cures. Dold also shared an update on the progress of the 21st Century Cures Act, a law to improve the process of federal research funding.

“It doesn’t do everything we want, but what [the 21st Century Cures Act] does do is it streamlines the bureaucracy and also provides much-needed resources to enable research to happen and to attract some of the best and brightest talent to be here,” Dold said.

A main concern for Alfred George, Jr., MD, chair of Pharmacology and director of the Center for Pharmacogenomics, was the potential to lose a generation of scientists because of a lack of funding to pursue their research.

“There are a lot of very talented people out there right now, and what keeps me up at night is the fact that a lot of these very talented people probably will not be in science or they will certainly not be working in academic science research careers,” Dr. George said.

The 21st Century Cures Act was approved by the U.S. House of Representatives in July and will be taken up by the U.S. Senate this fall. It contains provisions creating an “Innovation Fund,” which will invest $1.75 billion per year for the next five years into the National Institutes of Health (NIH) and $110 million per year for five years in the U.S. Food and Drug Administration (FDA). The bill also includes a special provision to invest more resources into the next generation of scientists.

Dimitri Krainc, MD, chair of Neurology and director of the Center for Rare Neurological Diseases raised concerns about barriers to collaboration and the need to incorporate patient perspectives into research.

“Patients don’t care about all the barriers we pose to each other in scientific work. They want us to work together; they want us to be smart about our work and to find these cures as soon as possible,” Dr. Krainc said.

The bill also contains measures to remove barriers to collaboration and incorporate patient perspectives into the drug development and regulatory review process.

In addition to the roundtable, Dold toured the laboratory of Elizabeth McNally, PhD, MD, director of the Center for Genetic Medicine and professor of Cardiology in the Department of Medicine.

Along with her colleagues, Dr. McNally, who is also a professor of Biochemistry and Molecular Genetics, explained new therapies and procedures they are currently testing. She also shared news from her recent visit to Washington, DC, where she testified before the House Subcommittee on Research and Technology about the science and ethics of genetically engineered human DNA.

At the end of the event, Dold thanked the scientists for their work and asked for their continued support and guidance.

“What you are doing each and every day impacts lives, and we certainly appreciate what you are doing,” Dold said. “I am going to come back and ask all of you to be our champions and ambassadors and arm me with the stories that are happening here and at neighboring facilities.”

Events Faculty Research
Share. Facebook Twitter Email

Related Posts

Celebrating Advances in Alzheimer’s Research and Clinical Care

May 26, 2023

Understanding How Hormones Influence Anemia

May 25, 2023

Groundbreaking Geneticist Delivers Epigenetics Lecture

May 24, 2023

Comments are closed.

Latest News

Celebrating Advances in Alzheimer’s Research and Clinical Care

May 26, 2023

Understanding How Hormones Influence Anemia

May 25, 2023

Groundbreaking Geneticist Delivers Epigenetics Lecture

May 24, 2023

CT Scan Best at Predicting Heart Disease Risk in Middle Age

May 23, 2023

Investigating the Benefits of Salt Substitutes in Elderly Patients

May 22, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20230506_NM569
20230506_NM564
20230506_NM563
20230506_NM559
20230506_NM555
20230506_NM549
20230506_NM508
20230506_NM474
20230506_NM136
20230506_NM124
20230506_NM118
20230506_NM094

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.